Young men who have sex with men report low levels of HIV prevention fatigue and HIV treatment optimism
METHODS: As part of a longitudinal study, a group of 352 racially- and ethnically-diverse YMSM (mean age = 19.9 years) completed measures of HIV prevention fatigue, treatment optimism, HIV risk behaviors, HIV-related knowledge, and likelihood of using PrEP at two timepoints 18 months apart.
RESULTS: Overall, YMSM reported low levels of HIV prevention fatigue and treatment optimism, which both decreased significantly over 18 months. Consistent with past studies, bivariate analyses showed that greater prevention fatigue was associated with HIV risk behaviors and HIV-positive serostatus. Multivariate analyses revealed that significant predictors of prevention fatigue included longer time since sexual debut and using drugs or alcohol before sex. Treatment optimism was predicted by number of condomless sex partners.
CONCLUSIONS: Results are inconsistent with the hypothesis of high levels of prevention fatigue in YMSM and suggest that YMSM remain receptive to HIV prevention messages. However, as prevention fatigue may increase for YMSM who have been sexually active for longer periods of time, closer attention to the design of HIV prevention interventions may help attenuate fatigue and ensure that messages remain compelling for YMSM.
Learning Areas:Implementation of health education strategies, interventions and programs
Social and behavioral sciences
Describe the concept of HIV prevention fatigue. Describe the extent to which young men who have sex with men report HIV prevention fatigue.
Keyword(s): Lesbian, Gay, Bisexual and Transgender (LGBT), HIV/AIDS
Qualified on the content I am responsible for because: I have conducted research and have worked as a healthcare provider in the field of sexual health, HIV, and HIV prevention for the last eight years. I have directed two federally funded grants focusing on sexual health and HIV prevention in young adults and adolescents.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.